Mogy Joel R Investment Counsel Inc increased its stake in Idexx Labs Inc (IDXX) by 2.7% based on its latest 2018Q3 regulatory filing with the SEC. Mogy Joel R Investment Counsel Inc bought 1,406 shares as the company’s stock declined 20.36% with the market. The institutional investor held 53,401 shares of the health care company at the end of 2018Q3, valued at $13.33M, up from 51,995 at the end of the previous reported quarter. Mogy Joel R Investment Counsel Inc who had been investing in Idexx Labs Inc for a number of months, seems to be bullish on the $18.18 billion market cap company. The stock increased 0.50% or $1.06 during the last trading session, reaching $211.32. About 484,156 shares traded. IDEXX Laboratories, Inc. (NASDAQ:IDXX) has risen 22.67% since February 20, 2018 and is uptrending. It has outperformed by 22.67% the S&P500.

Reik & Co decreased its stake in Tiffany & Co New Com (TIF) by 1.59% based on its latest 2018Q3 regulatory filing with the SEC. Reik & Co sold 4,510 shares as the company’s stock declined 31.54% with the market. The institutional investor held 279,873 shares of the consumer specialties company at the end of 2018Q3, valued at $36.10M, down from 284,383 at the end of the previous reported quarter. Reik & Co who had been investing in Tiffany & Co New Com for a number of months, seems to be less bullish one the $11.02B market cap company. The stock decreased 0.50% or $0.45 during the last trading session, reaching $90.38. About 1.10 million shares traded. Tiffany & Co. (NYSE:TIF) has declined 10.90% since February 20, 2018 and is downtrending. It has underperformed by 10.90% the S&P500. Some Historical TIF News: 16/03/2018 – TIFFANY & CO – INCREASING INVESTMENT NOW IN CERTAIN AREAS ARE EXPECTED TO HINDER PRE-TAX EARNINGS GROWTH IN NEAR-TERM; 16/05/2018 – National Storage Affiliates Trust Announces the Appointment of Tiffany S. Kenyon as Senior Vice President and Senior Legal; 16/03/2018 – TIFFANY & CO – MANAGEMENT REITERATES AND ELABORATES ON FISCAL 2018 GUIDANCE; 23/05/2018 – TIFFANY & CO – BOARD AUTHORIZES $1 BLN SHARE REPURCHASE PROGRAM; 12/03/2018 – French fashion designer Hubert de Givenchy designed Audrey Hepburn’s little black dress in “Breakfast at Tiffany’s.”; 15/05/2018 – MILLENNIUM ADDED NKTR, TIF, APTV, UTX, WP IN 1Q: 13F; 16/03/2018 – TIFFANY 4Q ADJ EPS $1.67, EST. $1.64; 23/05/2018 – TIFFANY & CO – SEES MID-TO-HIGH-SINGLE-DIGIT COMPARABLE SALES GROWTH FOR 2018; 16/03/2018 – Tiffany holiday quarter results beat estimates; 16/03/2018 – Tiffany quarterly revenue rises 8.5 pct on strong holiday quarter

More notable recent Tiffany & Co. (NYSE:TIF) news were published by: Gurufocus.com which released: “Steve Mandel Starts 6 New Positions in 4th Quarter – GuruFocus.com” on February 19, 2019, also Gurufocus.com with their article: “4 Stocks to Love on Valentine’s Day – GuruFocus.com” published on February 14, 2019, Seekingalpha.com published: “Tiffany: Global Events Jeopardize Tiffany’s Strategic Position – Seeking Alpha” on January 29, 2019. More interesting news about Tiffany & Co. (NYSE:TIF) were released by: Globenewswire.com and their article: “New Research: Key Drivers of Growth for Tiffany, CarMax, Cars, RPC, Cleveland-Cliffs, and Catabasis Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production – GlobeNewswire” published on January 29, 2019 as well as Streetinsider.com‘s news article titled: “JANA Partners Enters Centene (CNC), Mastercard (MA), Salesforce (CRM); Raises Microsoft (MSFT), Lowers Apple (AAPL) (More…) – StreetInsider.com” with publication date: February 14, 2019.

Analysts await Tiffany & Co. (NYSE:TIF) to report earnings on March, 15. They expect $1.71 EPS, up 2.40% or $0.04 from last year’s $1.67 per share. TIF’s profit will be $208.44 million for 13.21 P/E if the $1.71 EPS becomes a reality. After $0.77 actual EPS reported by Tiffany & Co. for the previous quarter, Wall Street now forecasts 122.08% EPS growth.

Investors sentiment increased to 1.04 in Q3 2018. Its up 0.03, from 1.01 in 2018Q2. It improved, as 25 investors sold IDXX shares while 207 reduced holdings. 82 funds opened positions while 159 raised stakes. 70.63 million shares or 1.73% less from 71.88 million shares in 2018Q2 were reported. Tru Of Vermont has invested 0.01% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Confluence Wealth Ltd Liability Com has 0.35% invested in IDEXX Laboratories, Inc. (NASDAQ:IDXX) for 2,687 shares. Northwestern Mutual Wealth Management stated it has 0% of its portfolio in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Kcm Investment Advsr Ltd Liability accumulated 0.01% or 965 shares. Commerzbank Aktiengesellschaft Fi holds 17,884 shares or 0.04% of its portfolio. Assetmark holds 48,112 shares. 3,729 are held by Thrivent Fin For Lutherans. Hanseatic Mngmt Serv stated it has 4,296 shares or 1% of all its holdings. Willingdon Wealth Mngmt has invested 0.01% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). Shell Asset Mngmt accumulated 0.03% or 6,430 shares. Obermeyer Wood Inv Counsel Lllp owns 7,972 shares. Asset Mngmt One Ltd owns 149,039 shares or 0.08% of their US portfolio. Barclays Pcl owns 170,651 shares or 0.03% of their US portfolio. Massachusetts-based Martingale Asset Mgmt Limited Partnership has invested 0.01% in IDEXX Laboratories, Inc. (NASDAQ:IDXX). The New York-based Tower Capital Ltd (Trc) has invested 0% in IDEXX Laboratories, Inc. (NASDAQ:IDXX).

More notable recent IDEXX Laboratories, Inc. (NASDAQ:IDXX) news were published by: Nasdaq.com which released: “IDEXX (IDXX) Q4 Earnings Top Estimates, Raises ’19 EPS View – Nasdaq” on February 01, 2019, also Nasdaq.com with their article: “Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy? – Nasdaq” published on January 25, 2019, Nasdaq.com published: “Consolidated Research: 2019 Summary Expectations for First Data, IDEXX Laboratories, CMS Energy, Worthington Industries, Triumph Group, and Cara Therapeutics — Fundamental Analysis, Key Performance Indications – Nasdaq” on January 24, 2019. More interesting news about IDEXX Laboratories, Inc. (NASDAQ:IDXX) were released by: Nasdaq.com and their article: “ZBH & IDXX Q4 Earnings on Feb 1: Here are the Key Predictions – Nasdaq” published on January 31, 2019 as well as Nasdaq.com‘s news article titled: “Here’s Why Momentum Investors Will Love Idexx Laboratories (IDXX) – Nasdaq” with publication date: February 13, 2019.